H.R. 8139 · 116th Congress
SUPPLIES Act of 2020
- Stage
- In committee
- Sponsor
- Gus Bilirakis
- Introduced
- 2020-09-01
- Latest action
- 2020-09-01 · Introduced in House
Summary
Surplus Utilization of Pharmaceutical Products Leveraged In Emergency Scenarios Act of 2020 or the SUPPLIES Act of 2020
This bill excludes certain short-dated drugs from rebate calculations under the Medicaid Drug Rebate Program during the public health emergency relating to COVID-19 (i.e., coronavirus disease 2019). Specifically, the bill excludes from such calculations direct sales of drugs that (1) have a shelf life of one year or more and expire one year after the date of sale, or (2) have a shelf life of less than one year and expire after the same number of days as the shelf life following the date of sale.